UCSF

ZINC03831128

Substance Information

In ZINC since Heavy atoms Benign functionality
September 30th, 2005 32 No

CAS Numbers: , 84371-65-3

Other Names:

(11beta,17beta)-11-(4-(Dimethylamino)-phenyl)-17-hydroxy-17-(1-propynyl)estra-4,9-dien-3-one

(11beta,17beta)-11-(4-(Dimethylamino)-phenyl)-17-hydroxy-17-(1-propynyl)estra-4,9-dien-3-one; (11beta,17beta)-11-(4-(Dimethylamino)phenyl)-17-hydroxy-17-(1-propynyl)-estra-4,9-dien-3-one; 11beta-(4-(Dimethylamino)phenyl)-17-hydroxy-21-methyl-19-nor-17alph

(11beta,17beta)-11-(4-(Dimethylamino)phenyl)-17-hydroxy-17-(1-propynyl)-estra-4,9-dien-3-one

(11beta,17beta)-11-(4-(Dimethylamino)phenyl)-17-hydroxy-17-(1-propynyl)estra-4,9-dien-3-one

(11beta,17beta)-11-[4-(dimethylamino)phenyl]-17-hydroxy-17-prop-1-yn-1-ylestra-4,9-dien-3-one

(8S,11R,13S,14S,17S)-11-(4-dimethylaminophenyl)-17-hydroxy-13-methyl-17-prop-1-ynyl-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-one

pristone

11-(4-DIMETHYLAMINO-PHENYL)-17-HYDROXY-13-METHYL-17-PROP-1-YNYL-1,2,6,7,8,11,12,13,14,15,16,17-DODEC AHYDRO-CYCLOPENTA[A]PHENANTHREN-3-ONE

11-[4-(dimethylamino)phenyl]-17-hydroxy-17-(prop-1-yn-1-yl)estra-4,9-dien-3-one

11beta-(4-(Dimethylamino)phenyl)-17-hydroxy-21-methyl-19-nor-17alpha-pregna-4,9-dien-20-m-3-on

11beta-(4-(Dimethylamino)phenyl)-17beta-hydroxy-17-(1-propynyl)estra-4,9-dien-3-on

11beta-(4-(N,N-Dimethylamino)phenyl)-17alpha-(prop-1-ynyl)-delta4,9-estradiene-17beta-ol-3-one

11beta-(4-Dimethyl-?amino)-?phenyl-17beta-hydroxy-17-(1-propynyl)-?estra-4,9-dien-3-one

11beta-(p-(Dimethylamino)phenyl)-17beta-hydroxy-17-(1-propynyl)estra-4,9-dien-3-one

122742-25-0

17-beta-Hydroxy-11-beta-(4-dimethylaminophenyl-1)-17-alpha-(prop-1-ynyl)oestra-4,9-dien-3-one

83203-42-3

84371-65-3

84371-65-3; C07652; Mifepristone; RU-486

84371-65-3; D00585; Korlym (TN); Mifeprex (TN); Mifepristone (USAN/INN)

84371-65-3; Mifepristone; Prestwick_570

AC1L1IOO

Ambap84371-65-3

BIDD:PXR0123

BPBio1_000262

BRD-K37270826-001-04-5

BRN 5779404

BSPBio_000238

C-1073

C07652

C29H35NO2

CHEBI:40057; CHEBI:6934

CHEBI:50692

CHEMBL157

CI-1073

CID55245

Contragest Brand of Mifepristone

Corlux

CPD000058481

CPD000058481; MIFEPRISTONE

CPD000058481; MIFEPRISTONE; SAM001246881

D00585

D015735

Danco Brand of Mifepristone

DAP000090

DB00834

Estra-4,9-dien-3-one, 11-(4-(dimethylamino)phenyl)-17-hydroxy-17-(1-propynyl)-, (11-beta,17-beta)-

Estra-4,9-dien-3-one, 11-(4-(dimethylamino)phenyl)-17-hydroxy-17-(1-propynyl)-, (11beta,17beta)-

estra-4,9-dien-3-one, 11-[4-(dimethylamino)phenyl]-17-hydroxy-17-(1-propynyl)-, (11b,17b)-

EU-0100801

Exelgyn Brand of Mifepristone

FDA

FT-0082666

HMS1568L20

HMS2052L05

HMS2090L22

HSCI1_000369

HSDB 6841

INN

Korlym

LS-64723

M 8046

M8046_SIGMA

MFCD00867226

MI

Mifegyne

Mifeprex

Mifeprex (TN)

Mifepriston

Mifepriston;RU486

Mifepristona

Mifepristona [Spanish]

Mifepristone (BAN

Mifepristone (Mifeprex)

Mifepristone (USAN/INN)

Mifepristone Contragest Brand

Mifepristone Danco Brand

Mifepristone Exelgyn Brand

Mifepristone [USAN:INN:BAN]

Mifepristonum

Mifepristonum [Latin]

MLS000069785

MLS001074115

MolPort-003-849-222

NCGC00025179-05

NCGC00025179-08

NCGC00179632-01

Pencrofton

Pictovir

Pictovir (TM)

Prestwick0_000299

Prestwick1_000299

Prestwick2_000299

Prestwick3_000299

Prestwick_570

R 38486

R-38486

R38486

RU 38486

RU 486

RU 486-6

RU-38486

RU-38486; RU-486

RU-486

RU-486, Mifegyne

RU-486, MIFEPRISTONE

RU-486, RU-38486, Mifegyne, Mifeprex, Mifepristone

RU38486

RU486

S1611_Selleck

SAM001246881

SMR000058481

SPBio_002457

Spectrum5_002045

TL8005515

UNII-320T6RNW1F

USAN)

VGX-410

VGX-410C

VX-410

ZINC03831128

ZK 98296

ZK-98296

ZK98296

Download: MOL2 SDF SMILES Flexibase

Annotations

Vendors

Physical Representations

Type pH range xlogP Des A‑Pol Apolar desolvation (kcal/mol) Des Pol Polar desolvation (kcal/mol) H Don H-bond donors H Acc H-bond acceptors Chg Net charge tPSA (Ų) MWT Molecular weight (g/mol) RB Rotatable bonds DL
Ref Reference (pH 7) 5.60 12.13 -10.13 1 3 0 41 429.604 2
Ref Reference (pH 7) 6.34 10.15 -7.73 2 3 0 44 429.604 2
Lo Low (pH 4.5-6) 6.34 10.92 -70.79 3 3 0 45 430.612 2

Vendor Notes

Note Type Comments Provided By
MP 195 TCI
ALOGPS_SOLUBILITY 3.36e-03 g/l DrugBank-approved
Purity 99% APIChem
Patent Database Links EP1726307; EP1738759; EP1862182; EP1870089; EP1886695; EP1941886; EP1987820; EP1990044; US2004142904; US2007179113; US2007190022; US2007196269; US2007197488; US2007213306; US2007254858; US2007258951; US2007259014; US2007259844; US2007270393; US2008057068 ChEBI
Target Estrogen/progestogen Receptor Selleck Chemicals
PUBCHEM_SUBSTANCE_COMMENT NCC_SAMPLE_SUPPLIER : Sigma Chemical Company; NCC_SUPPLIER_STRUCTURE_ID : M8046 NIH Clinical Collection via PubChem
Therapy progesterone antagonist, abortion inducer SMDC Pharmakon
PUBCHEM_SUBSTANCE_COMMENT SAMPLE_SUPPLIER: Sigma Chemical Company; SUPPLIER_STRUCTURE_ID: M8046 NIH Clinical Collection via PubChem

Activity (Go SEA)

Clustered Target Annotations
Code Description Organism Class Affinity (nM) LE (kcal/mol/atom) Type
PRGR-1-E Progesterone Receptor (cluster #1 Of 3), Eukaryotic Eukaryotes 1 0.39 Binding ≤ 10μM
PRGR-2-E Progesterone Receptor (cluster #2 Of 2), Eukaryotic Eukaryotes 0 0.00 Functional ≤ 10μM
ChEMBL Target Annotations
Uniprot Swissprot Description Affinity (nM) LE (kcal/mol/atom) Type
PRGR_HUMAN P06401 Progesterone Receptor, Human 1.1 0.39 Binding ≤ 1μM
PRGR_HUMAN P06401 Progesterone Receptor, Human 1.1 0.39 Binding ≤ 10μM
PRGR_HUMAN P06401 Progesterone Receptor, Human 0.3 0.42 Functional ≤ 10μM

Reactome Annotations from Targets (via Uniprot)

Description Species
Nuclear Receptor transcription pathway
Nuclear signaling by ERBB4

Analogs ( Draw Identity 99% 90% 80% 70% )